Connect with:
Wednesday / March 12. 2025

logo
mobile-logo
HomePosts Tagged "Biotalys"
Agbiologicals, Agribusiness, Agrotech, Fungicides, R&D

BioFun-6, company’s second biocontrol program showed excellent efficacy against Botrytis and powdery mildew in fruits and vegetables.

Biotalys (Euronext Brussels: BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, announced strong performance from initial field trials with one of its lead candidates for BioFun-6, the company’s second biocontrol program against Botrytis and powdery mildew in fruits and vegetables.

The trial results demonstrated that the BioFun-6 AGROBODYTM candidate is an effective tool to protect crops against these key pathogens, at significantly lower dose rates than currently applicable for EVOCA™*, the company’s first biofungicide.

Kevin Helash, CEO of Biotalys, said: “We are very pleased with the outcome of these promising field trials, which further validate the potential of our AGROBODY technology platform to deliver highly effective protein-based crop protection solutions. The data support BioFun-6’s efficacy in controlling fungi at significantly reduced dosage rates, — a key milestone toward our goal of offering cost-effective, sustainable products to growers across diverse crops and pathogens. I’m incredibly proud of what our team has achieved and grateful for their dedication, bringing us closer to monetizing our portfolio while creating value for our growers, partners, and shareholders.”

The trials were commissioned by Biotalys and conducted in Europe and the U.S. by external contract research organisations (CRO’s). The BioFun-6 AGROBODY candidate was tested at different dose rates in grapes against Botrytis (grey mold), and in cucumbers and tomatoes against powdery mildew. BioFun-6 was compared with synthetic and biological solutions, both in a standard spray rotation program and as a stand-alone treatment.

The results showed that the BioFun-6 AGROBODY biocontrol can achieve the same level of performance as EVOCA at significantly lower dosage rates, highlighting the increased potency of the new candidate. When applied at 2/3 the dose rate of EVOCA, the tested BioFun-6 candidate proved to be a valid substitution to leading chemical products against Botrytis in grapes. Applied at half the dose rate of EVOCA, the tested candidate maintained the same disease suppression as EVOCA against powdery mildew in cucumber and outperformed a standard biological fungicide. ** The first set of trials in tomatoes showed similar results.

Biotalys’ BioFun-6 program is addressing a current market of more than USD billion 1.2 in Europe and the US combined. The global market for biofungicides and bioinsecticides is expected to grow by approximately 12% per year, reaching more than USD 17 billion in 2030, representing nearly a quarter of the total market for fungicides and insecticides. *** Biotalys plans to test various BioFun-6 AGROBODY lead candidates in the field throughout 2025, while further assessing their producibility and scalability.

BioFun-6, company’s second biocontrol program showed excellent

Agro chems – Pesticides, Agrotech, Company News, Europe, R&D

Syngenta to leverage Biotalys’ AGROBODY™ technology platform to expand insecticide biocontrol pipeline

Switzerland based Syngenta Crop Protection and Biotalys (Euronext – BTLS) today announced a collaboration to research, develop and commercialize new biocontrol solutions to manage key pests in a broad variety of crops. The new solution will be based on Biotalys’ AGROBODYTM technology and will offer a new mode of action to broaden farmers’ access to novel technologies that counter the threat of pest resistance and advance sustainable agriculture.

Under the terms of this partnership, Syngenta will collaborate on a research program with Biotalys, an agricultural technology company focused on protein-based biocontrol solutions, to leverage its AGROBODY™ technology platform for Syngenta’s specific insect targets.

“Syngenta is a leader in bringing farmers cutting edge technologies that improve the sustainability of agriculture, and we are excited to work closely with Biotalys as part of our agricultural innovation ecosystem,” said Camilla Corsi, Head of Crop Protection Research at Syngenta Crop Protection. “By combining our proven research and development capabilities with the breakthrough protein-based innovations of the Biotalys AGROBODY™ platform, we are determined to play a pivotal role in addressing critical farmer needs around the globe.”

With resistance development and increasing regulatory and environmental pressures, growers are eager to explore innovative and effective biological solutions that limit the impact on the environment and biodiversity. Biotalys has demonstrated the potential of its protein-based biocontrols to deliver novel modes of actions for effective and safe application in food and agriculture. This new partnership allows Biotalys to accelerate the development and global commercialization of innovative crop protection solutions and cement its biocontrol innovation leadership by leveraging the expansive network and capabilities of a global agriculture business.

“We are proud and excited to be working with Syngenta, a world-leading agricultural company, on one of the most pressing industry challenges – the development of innovative and effective pest control solutions – by delivering on the promise of our AGROBODY™ technology,” said Patrice Sellès, Chief Executive Officer at Biotalys. “Collaborating with Syngenta is a major milestone in our continued mission to providing growers around the globe with safe, efficient, and more sustainable agricultural solutions.”

Syngenta to leverage Biotalys’ AGROBODY™ technology platform

Agrotech, Company News

Evoca helps sustainably control economically important fungal diseases such as Botrytis and powdery mildew in fruits and vegetables.

Novozymes and Biotalys, an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions have announced the successful outcome of the feasibility study for Evoca™*, Biotalys’ first proprietary biocontrol product candidate. 

Novozymes obtained proof of concept for a new manufacturing process that offers potential significant cost of goods and scaling advantages, thereby broadening the commercial potential of Evoca as a novel biofungicide.

Evoca is Biotalys’ first innovative protein-based biofungicide developed on the company’s AGROBODY Foundry™ platform which platform allows Biotalys to discover and develop novel biological food protection solutions that combine high efficacy, consistency and safety, with new modes of action to fight resistance. 

Evoca helps sustainably control economically important fungal diseases such as Botrytis and powdery mildew in fruits and vegetables.

“Thanks to its leading protein fermentation expertise, Novozymes has been able to further increase the efficiency of production for Evoca,” said Patrice Sellès, the CEO of Biotalys. “We will now work on a deeper partnership with Novozymes and explore strategic supply and commercialization agreements for the future generation of Evoca while continuing our ongoing internal development activities.”
“Now one step closer to large-scale production, Biotalys and Novozymes have successfully collaborated to provide the industry and growers new ways to safely control damaging pests and diseases and deliver our shared goal of providing highly effective solutions so growers can sustainably feed the world.” Noted Thomas Batchelor, Vice President, Agriculture Marketing and Strategy of Novozymes. 

Evoca helps sustainably control economically important fungal